Inclusion of patients with brain metastases in phase I trials: An unmet need Journal Article


Authors: Gounder, M. M.; Spriggs, D. R.
Article Title: Inclusion of patients with brain metastases in phase I trials: An unmet need
Abstract: Patients with brain metastases are increasing in number; however, these patients are often excluded in phase I/II trials due to perceived poor prognosis, risk of hemorrhage, inefficient drug delivery, and confounding toxicities. Tsimberidou and colleagues demonstrate that selected patients can be appropriately enrolled in phase I trials and have outcomes representative of the general cancer population. ©2011 AACR.
Keywords: treatment failure; overall survival; cytotoxic agent; drug efficacy; drug safety; note; cancer radiotherapy; fever; brain metastasis; phase 1 clinical trial (topic)
Journal Title: Clinical Cancer Research
Volume: 17
Issue: 12
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2011-06-15
Start Page: 3855
End Page: 3857
Language: English
DOI: 10.1158/1078-0432.ccr-11-0759
PROVIDER: scopus
PUBMED: 21527561
DOI/URL:
Notes: --- - "Export Date: 17 August 2011" - "CODEN: CCREF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mrinal M Gounder
    228 Gounder
  2. David R Spriggs
    325 Spriggs